VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tunica Albuginea who wrote (5564)	2/20/1998 10:34:00 PM
From: Cacaito	Read Replies (5) of 23519

HVSFD "patent" claims an "intrameatal" delivery, they are calling the opening of the urethra (the meatus) a different anatomic part of the penis,at least different enough to justify their "patent". A different word to keep selling their worthless stock. This will not hold in any court, one only need a dictionary to see it. Meatus urinarius: opening part of the urethra. So if it is delivered intrameatally, it is the same as delivered intraurethrally and cover by Vivus patent.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next